,i #aahth ,,congress #ast ,session ,h4 ,r4 #eggc ,,in ,,the ,,house ,,of ,,representatives ,september #bg1 #bjbc,mr4 ,posey introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,public ,health ,service ,act to remove certain liability protections for certain biological products and other drugs if the sponsor thereof fails to disclose to the public all non-exempt data within the biological product file or drug application1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,consumer ,vaccine ,safety and ,protection ,act of #bjbc4 #b4 ,disclosure of non-exempt data required for certain biological products and other drugs ,section #cai;,f-#c of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#f;b7 is amended by adding at the end the following3 7j7 ,disclosure of non-,exempt data required 7#a7 ,covered products ,in this subsection1 the term covered product means a covered countermeasure that-- 7,a7 is a biological product or other drug2 and 7,b7 is authorized for emergency use under section #efd of the ,federal ,food1 ,drug1 and ,cosmetic ,act on or after the date of enactment of the ,consumer ,vaccine ,safety and ,protection ,act of #bjbc1 irrespective of whether the biological product or drug later receives approval or licensure under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act or section #cea of this ,act4 7#b7 ,disclosure by sponsors 7,a7 ,in general ,subject to subparagraph 7,c71 the sponsor of a covered product shall disclose to the public1 in an easily accessible location on the website of the sponsor of the covered product-- 7i7 in the case of a biological product1 all data and information available for public disclosure under section #fja4ea7;e7 of title #ba1 ,code of ,federal ,regulations 7or successor regulations72 and 7ii7 in the case of another drug1 all data and information available for public disclosure under section #cad4dcj of title #ba1 ,code of ,federal ,regulations 7or successor regulations74 7,b7 ,timing ,the sponsor of a covered product shall1 with respect to any data or information required to be disclosed by subparagraph 7,a71 make the disclosure not later than #aj days after the later of-- 7i7 the date on which the ,food and ,drug ,administration authorizes the emergency use of the covered product under section #efd of the ,federal ,food1 ,drug1 and ,cosmetic ,act2 and 7ii7 the date on which the data or information becomes available to the sponsor4 7,c7 ,exceptions ,the disclosure requirement in subparagraph 7,a7 does not apply with respect to-- 7i7 a trade secret or confidential commercial or financial information as defined in section #bj4fa of title #ba1 ,code of ,federal ,regulations 7or successor regulations72 or 7ii7 personally identifiable information4 7#c7 ,disclosure by ,,hhs 7,a7 ,in general ,subject to subparagraph 7,b71 the ,secretary shall-- 7i7 not later than #aj days after the ,food and ,drug ,administration authorizes the emergency use of a covered product under section #efd of the ,federal ,food1 ,drug1 and ,cosmetic ,act or approves or licenses a covered product under section #eje of such ,act or section #cea of this ,act1 disclose to the public1 in an easily accessible location on the website of the ,department of ,health and ,human ,services1 all data and information required by paragraph 7#b7 to be disclosed by the sponsor of the product2 and 7ii7 not later than #cj days after receiving any additional such data and information1 so disclose such data and information4 7,b7 ,exception ,the disclosure requirement in subparagraph 7,a7 does not apply with respect to data and information exempted from disclosure by paragraph 7#b77;,c74 7#d7 ,enforcement against sponsors for failure to disclose 7,a7 ,exclusion from definition of covered countermeasure ,notwithstanding subsection 7i77#a71 a covered product is deemed to be excluded from the definition of a covered countermeasure for purposes of the provisions of this section 7other than this subsection7 and section #cai;,f-#d if-- 7i7 the covered product is administered on or after the date of enactment of the ,consumer ,vaccine ,safety and ,protection ,act of #bjbc2 and 7ii7 the sponsor of the covered product is determined by the ,secretary to have knowingly failed to make a disclosure required by paragraph 7#b7 with respect to the covered product4 7,b7 ,ineligibility for ,,fda awards1 funds1 or other benefits ,if the sponsor of a covered product is determined by the ,secretary to have knowingly failed to make a disclosure required by paragraph 7#b7 with respect to the covered product1 such sponsor shall be treated as ineligible for the award of any grant1 cooperative agreement1 or loan or for any new grant of emergency use authorization1 expanded access1 or approval or licensure of any product under section #cea of this ,act or any provision of the ,federal ,food1 ,drug1 and ,cosmetic ,act so long as such sponsor continues to be in violation of such requirement4 7#e7 ,enforcement against ,,hhs for failure to disclose ,a party injured by a covered product with respect to which the ,secretary failed to carry out the ,secretary's duties under paragraph 7#c7 may bring an action in the appropriate district court of the ,united ,states for appropriate relief1 including damages4 4